NDC 61755-019
Inmazeb 483.3 mg per 14.5 mL injection, solution
On the label: Regeneron Pharmaceuticals, Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Regeneron Ireland Designated Activity Company | Limerick, Ireland | Makes the active ingredient and tests it | Problems found, fixed voluntarilyJun 13, 2025 · 2 inspections |
| Regeneron Pharmaceuticals, Inc. | Rensselaer, NY, United States | Tests it | Problems found, fixed voluntarilyMar 22, 2024 · 10 inspections |
Product details
- Generic drug
- Atoltivimab and Maftivimab and Odesivimab: every company that makes it
- Form
- injection, solution, intravenous
- Strength
- 483.3 mg per 14.5 mL
- Approval
- BLA BLA761169
- On the market since
- Jul 29, 2021
- Package NDCs
61755-019-0061755-019-01- Official label
- DailyMed (National Library of Medicine), updated Dec 15, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?